Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2022-02-03 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Lupin Quarter 3 FY2022 Results.
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report from Lupin Limited covering unaudited financial results for the quarter and nine months ended December 31, 2021. It includes comprehensive financial data such as sales, EBITDA, profit before tax, segment-wise sales, and commentary from the Managing Director. The presence of consolidated income statements, balance sheet highlights, and detailed financial metrics for Q3 FY2022 and 9M FY2022 indicates this is a periodic financial report shorter than a full fiscal year. The document is not merely an announcement or a press release stating that a report is attached; it contains substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-02-03 English
Unaudited standalone and consolidated financial results for the quarter and nine-months ended December 31, 2021.
Regulatory Filings
2022-02-03 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial statement titled 'STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2021' from Lupin Limited. It includes comprehensive financial data such as revenue, expenses, profit/loss before tax, tax expenses, and net profit/loss for multiple periods including quarterly and nine-month periods. The document references compliance with SEBI Listing Regulations and includes limited review reports from statutory auditors. The presence of unaudited standalone and consolidated financial results for a quarter and nine months indicates this is an Interim / Quarterly Report. The document length (15,000 characters) and detailed financial data confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2022-02-03 English
Lupin and Axantia Enter into a License, Supply and Technology Sharing Agreement for Pegfilgrastim in the Middle East and North Africa.
Regulatory Filings Classification · 95% confidence The document is a press release announcing a License, Supply and Technology Sharing agreement between Lupin Limited and Axantia Holding. It is addressed to stock exchanges and references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content focuses on the business agreement and does not contain financial statements, management discussion, or detailed financial data. The document length is 5652 characters, which is relatively short and typical for a regulatory disclosure or announcement rather than a full report. There is no indication that this is an earnings release, annual report, or other financial report. The document is a regulatory announcement of a material event (business agreement) pursuant to listing regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-02-01 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a License, Supply and Technology Sharing agreement between Lupin Limited and Axantia Holding. It is addressed to stock exchanges and references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content focuses on a business agreement and does not contain financial statements, earnings data, or detailed financial analysis. It is not a report, transcript, or regulatory filing of financial results but a corporate announcement about a strategic partnership. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a significant business agreement impacting the company's operations and potential market expansion.
2022-02-01 English
Intimation regarding issuance of duplicate share certificate.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It details the old and new share certificate numbers and the number of shares involved. This is a notification about a share certificate replacement due to loss, which is a regulatory compliance disclosure related to shareholding but does not involve changes in major shareholding levels or capital structure. It is not a financial report, earnings release, or management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-01-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.